KRAS Tests Market, by Technology (PCR, NGS, Array Technology, Other Technologies), by Application (Diagnostics, Research Application) and, by End User (Hospitals, Cancer Research Centers, Diagnostic Centers, Academic and Government Institutes): Opportunity Analysis and Industry Forecast, 2023-2032

The study on the Kras tests market offers insights, information, and recommendation to market stakeholders and investors to help them prioritize and formulate strategic decisions. The report includes Kras tests market across more than 15 countries. The study is analyzed on the basis of rigorous research methodology, which covers extensive desk research using qualitative analysis, quantitative/statistical methods, and primary interviews.

The study analyzes the market scope, revenue size, and growth of the global Kras tests market and monitors the prime trends at the regional level. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. The report includes a section on the company profile that covers the company overview, company snapshot, key executives, product/service portfolio, operating business segments, business performance, R&D expenditure, and key strategic moves & developments. The global Kras tests market is categorized on the basis of by technology, by application, by end user. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Spain, Italy, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Key players covered in this report are Agilent Technologies, Thermo Fisher Scientific, QIAGEN, Illumina, Bio-Rad Laboratories, Merck KGaA, PerkinElmer, Hoffmann-La Roche, Perceptive Instruments, Verogen

Deliverables:

• Market size value forecast by country

• Regional-level market trends and market dynamics

• Porter’s five forces model and PESTLE Analysis

• Company profile, competition landscape inclusive of heatmap analysis, competition dashboard and product/service offerings

• Major developmental strategies and M&A activities

• Country-wise market size and forecast for each segment

• Market share of leading players worldwide

Market Taxonomy

This report divides the global Kras tests market on the basis of by technology, by application, by end user. On the basis of region, the global Kras tests market analyzed across North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa.

  KRAS Tests Market, by Technology Report Highlights

Aspects	Details
By Technology	PCR NGS Array Technology Other Technologies
By Application	Diagnostics Research Application
By End User	Hospitals Cancer Research Centers Diagnostic Centers Academic and Government Institutes
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Verogen, Illumina, Hoffmann-La Roche, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Perceptive Instruments, Merck KGaA, QIAGEN, PerkinElmer

^*Terms and Conditions Apply